| Drug Name |
Ibutilide fumarate |
| Drug ID |
BADD_D01122 |
| Description |
Ibutilide is a Class III antiarrhythmic agent available in intravenous formulations. It is indicated for the conversion of acute atrial flutter and recent onset atrial fibrillation to normal sinus rhythm (NSR). |
| Indications and Usage |
Indicated for the rapid conversion of atrial fibrillation or atrial flutter of recent onset to sinus rhythm. |
| Marketing Status |
approved |
| ATC Code |
C01BD05 |
| DrugBank ID |
DB00308
|
| KEGG ID |
D00648
|
| MeSH ID |
C067192
|
| PubChem ID |
5281065
|
| TTD Drug ID |
D02MLW
|
| NDC Product Code |
0009-3794; 67457-366; 14474-040 |
| UNII |
9L5X4M5L6I
|
| Synonyms |
ibutilide | N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide | U-82209E | U82209E | Corvert | ibutilide, fumarate salt (2:1), (+-)-isomer | U-70226E | ibutilide, (+)-isomer | ibutilide, (+-)-isomer | ibutilide, (-)-isomer | ibutilide, fumarate salt (2:1), (+)-isomer | U-82208E | U82208E | ibutilide fumarate |
